133 related articles for article (PubMed ID: 11918281)
1. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study.
Prisco D; Antonucci E; Fedi S; Margheri M; Giglioli C; Comeglio M; Lombardi A; Chioccioli M; Abbate R; Gensini GF
Clin Exp Med; 2001 Dec; 1(4):219-24. PubMed ID: 11918281
[TBL] [Abstract][Full Text] [Related]
2. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
5. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
6. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
8. Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.
Parfyonova Y; Alekseeva I; Plekhanova O; Deev A; Titaeva E; Dobrovolsky A; Gabbasov Z; Lyakishev A; Tkachuk V
Heart Vessels; 2014 Sep; 29(5):611-8. PubMed ID: 24057344
[TBL] [Abstract][Full Text] [Related]
9. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
10. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty.
Simonton CA; Mark DB; Hinohara T; Rendall DS; Phillips HR; Peter RH; Behar VS; Kong Y; O'Callaghan WG; O'Connor C
J Am Coll Cardiol; 1988 Apr; 11(4):698-705. PubMed ID: 2965171
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
[TBL] [Abstract][Full Text] [Related]
12. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
[TBL] [Abstract][Full Text] [Related]
13. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
[TBL] [Abstract][Full Text] [Related]
14. Detection of intracoronary fibrin degradation after coronary balloon angioplasty.
Ring ME; Vecchione JJ; Fiore LD; Ruocco NA; Jacobs AK; Deykin D; Ryan TJ; Faxon DP
Am J Cardiol; 1991 Jun; 67(16):1330-4. PubMed ID: 2042563
[TBL] [Abstract][Full Text] [Related]
15. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
[TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
[TBL] [Abstract][Full Text] [Related]
18. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
Katz S; Green SJ; Kaplan BM; Chepurko L; Goldner BG; Ong L
Am Heart J; 2000 Jan; 139(1 Pt 1):44-51. PubMed ID: 10618561
[TBL] [Abstract][Full Text] [Related]
19. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T
Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
[TBL] [Abstract][Full Text] [Related]
20. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
